Revance Therapeutics, Inc. 10-Q and 10-Q/A reports

Location
1222 Demonbreun Street, Suite 2000, Nashville, Tennessee
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
5/10/2024, 04:16 AM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q May 9, 2024 Mar 31, 2024
10-Q Report | Data 10-Q Nov 8, 2023 Sep 30, 2023
10-Q Report | Data 10-Q Aug 8, 2023 Jun 30, 2023
10-Q Report | Data 10-Q May 9, 2023 Mar 31, 2023
10-Q Report | Data 10-Q Nov 8, 2022 Sep 30, 2022
10-Q Report | Data 10-Q Aug 9, 2022 Jun 30, 2022
10-Q Report | Data FORM 10-Q May 10, 2022 Mar 31, 2022
10-Q Report | Data 10-Q Nov 9, 2021 Sep 30, 2021
10-Q Report | Data 10-Q Aug 5, 2021 Jun 30, 2021
10-Q Report | Data 10-Q May 10, 2021 Mar 31, 2021
10-Q Report | Data 10-Q Nov 9, 2020 Sep 30, 2020
10-Q Report | Data 10-Q Aug 6, 2020 Jun 30, 2020
10-Q Report | Data 10-Q May 7, 2020 Mar 31, 2020
10-Q Report | Data 10-Q Nov 4, 2019 Sep 30, 2019
10-Q Report | Data 10-Q Aug 6, 2019 Jun 30, 2019
10-Q Report | Data 10-Q May 9, 2019 Mar 31, 2019
10-Q Report | Data 10-Q Nov 2, 2018 Sep 30, 2018
10-Q Report | Data 10-Q Aug 3, 2018 Jun 30, 2018
10-Q Report | Data 10-Q May 9, 2018 Mar 31, 2018
10-Q Report | Data 10-Q Nov 3, 2017 Sep 30, 2017
10-Q Report | Data 10-Q Aug 4, 2017 Jun 30, 2017
10-Q Report | Data 10-Q May 9, 2017 Mar 31, 2017
10-Q Report | Data 10-Q Nov 4, 2016 Sep 30, 2016
10-Q Report | Data 10-Q Aug 5, 2016 Jun 30, 2016
10-Q Report | Data 10-Q May 10, 2016 Mar 31, 2016
10-Q Report | Data 10-Q Nov 10, 2015 Sep 30, 2015
10-Q Report | Data 10-Q Aug 7, 2015 Jun 30, 2015
10-Q Report | Data 10-Q May 14, 2015 Mar 31, 2015
10-Q Report | Data FORM 10-Q Nov 13, 2014 Sep 30, 2014
10-Q Report | Data FORM 10-Q Aug 13, 2014 Jun 30, 2014
10-Q Report | Data 10-Q May 14, 2014 Mar 31, 2014